[1]CurrentPatentAssignee:VIFORPHARMALTD-US2012/214803,2012,A1Locationinpatent:Page/Pagecolumn167-168
[1]Patent:US2015/282482,2015,A1.Locationinpatent:Paragraph2211
[2]Patent:EP2926660,2015,A1.Locationinpatent:Paragraph0375
248270-23-7
773087-43-7
1704065-21-3
1704066-94-3
1704067-00-4
188723-93-5
70147-48-7 | 2C-Hydroxymethyl-2,3:5,6-di-o-isopropylidene-d-mannono-1,4-lactone | AA00FESD | MFCD09750771
670280-13-4 | 3-(Aminomethyl)benzenesulfonamide, HCl | AA00FFAE | MFCD10686807
66117-64-4 | Hydroxydip-tolylborane | AA00FFU9 | MFCD09972117
71676-00-1 | AMisulpride IMpurity D | AA00FG6H | MFCD01666750
681448-25-9 | 2-(4,4-Dimethylcyclohexyl)acetic acid | AA00FGFK | MFCD20319688
668273-75-4 | Tert-butyl((3s)-1-(7-(but-2-yn-1-yl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-2,6-dioxo-2,3,4,5,6,7-hexahydro-1h-purin-8-yl)piperidin-3-yl)carbaMate | AA00FGTK | MFCD22376710
727985-37-7 | (2-Bromo-5-methylphenyl)methanol | AA00FH1A | MFCD11847170
6827-40-3 | Diethyl 2-(4-chlorobenzylidene)malonate | AA00FHER | MFCD00018786
713512-18-6 | 1-bromo-4-iodo-2-nitrobenzene | AA00FHRV | MFCD12547765
670256-21-0 | 4-Bromo-2-(hydroxymethyl)benzoic acid | AA00FJSC | MFCD11977384